Hall Laurie J Trustee purchased a new stake in Stryker Corporation (NYSE:SYK) during the fourth quarter, according to its most recent 13F filing with the SEC. The institutional investor purchased 34,992 shares of the medical technology company’s stock, valued at approximately $4,120,000. Stryker Corporation makes up about 2.6% of Hall Laurie J Trustee’s portfolio, making the stock its 10th largest position.

Other hedge funds and other institutional investors have also recently added to or reduced their stakes in the company. Blue Chip Partners Inc. boosted its position in Stryker Corporation by 0.3% in the second quarter. Blue Chip Partners Inc. now owns 1,757 shares of the medical technology company’s stock worth $211,000 after buying an additional 6 shares in the last quarter. Wetherby Asset Management Inc. boosted its position in Stryker Corporation by 0.3% in the second quarter. Wetherby Asset Management Inc. now owns 6,242 shares of the medical technology company’s stock worth $748,000 after buying an additional 18 shares in the last quarter. Douglas Lane & Associates LLC boosted its position in Stryker Corporation by 0.7% in the second quarter. Douglas Lane & Associates LLC now owns 2,945 shares of the medical technology company’s stock worth $353,000 after buying an additional 20 shares in the last quarter. Wade G W & Inc. boosted its position in Stryker Corporation by 1.0% in the third quarter. Wade G W & Inc. now owns 2,230 shares of the medical technology company’s stock worth $260,000 after buying an additional 22 shares in the last quarter. Finally, Private Bank & Trust Co. boosted its position in Stryker Corporation by 0.5% in the third quarter. Private Bank & Trust Co. now owns 4,222 shares of the medical technology company’s stock worth $492,000 after buying an additional 23 shares in the last quarter. 74.89% of the stock is currently owned by hedge funds and other institutional investors.

Institutional Ownership by Quarter for Stryker Corporation (NYSE:SYK)

Shares of Stryker Corporation (NYSE:SYK) traded up 0.4650% during trading on Friday, hitting $123.8332. 509,458 shares of the company’s stock were exchanged. The stock has a market cap of $46.37 billion, a P/E ratio of 28.1823 and a beta of 0.84. Stryker Corporation has a one year low of $88.57 and a one year high of $127.23. The firm has a 50-day moving average price of $117.65 and a 200-day moving average price of $116.10.

Stryker Corporation (NYSE:SYK) last issued its quarterly earnings results on Thursday, October 27th. The medical technology company reported $1.39 EPS for the quarter, beating the consensus estimate of $1.37 by $0.02. The company had revenue of $2.83 billion for the quarter, compared to the consensus estimate of $2.81 billion. Stryker Corporation had a net margin of 15.24% and a return on equity of 23.61%. The firm’s revenue was up 17.1% compared to the same quarter last year. During the same period in the prior year, the firm posted $1.25 EPS. Equities research analysts expect that Stryker Corporation will post $5.78 EPS for the current fiscal year.

The company also recently declared a quarterly dividend, which will be paid on Tuesday, January 31st. Investors of record on Friday, December 30th will be issued a dividend of $0.425 per share. This represents a $1.70 annualized dividend and a yield of 1.38%. This is an increase from Stryker Corporation’s previous quarterly dividend of $0.38. The ex-dividend date is Wednesday, December 28th. Stryker Corporation’s dividend payout ratio is presently 38.72%.

ILLEGAL ACTIVITY WARNING: This news story was originally reported by Watch List News and is the sole property of of Watch List News. If you are reading this news story on another publication, it was copied illegally and reposted in violation of US & international trademark and copyright legislation. The original version of this news story can be viewed at http://www.watchlistnews.com/34992-shares-in-stryker-corporation-syk-acquired-by-hall-laurie-j-trustee/1060149.html.

SYK has been the topic of a number of research analyst reports. Zacks Investment Research raised Stryker Corporation from a “hold” rating to a “buy” rating and set a $119.00 target price on the stock in a research note on Tuesday, November 15th. SunTrust Banks, Inc. started coverage on shares of Stryker Corporation in a research report on Thursday, October 13th. They set a “buy” rating and a $140.00 price target for the company. Canaccord Genuity set a $127.00 price target on shares of Stryker Corporation and gave the company a “buy” rating in a research report on Sunday, October 30th. RBC Capital Markets restated a “buy” rating and set a $129.00 price target on shares of Stryker Corporation in a research report on Friday, January 6th. Finally, Edward Jones lowered shares of Stryker Corporation from a “buy” rating to a “hold” rating in a research report on Thursday, January 5th. Two investment analysts have rated the stock with a sell rating, eight have assigned a hold rating and thirteen have assigned a buy rating to the company’s stock. The stock currently has a consensus rating of “Hold” and an average price target of $122.95.

In other Stryker Corporation news, Director Ronda E. Stryker sold 12,000 shares of the business’s stock in a transaction dated Monday, October 17th. The shares were sold at an average price of $113.95, for a total value of $1,367,400.00. Following the completion of the sale, the director now directly owns 193,142 shares of the company’s stock, valued at approximately $22,008,530.90. The transaction was disclosed in a filing with the SEC, which is available through this link. Also, Director Ronda E. Stryker sold 18,000 shares of the business’s stock in a transaction dated Tuesday, November 15th. The shares were sold at an average price of $109.53, for a total transaction of $1,971,540.00. Following the completion of the sale, the director now directly owns 193,142 shares of the company’s stock, valued at $21,154,843.26. The disclosure for this sale can be found here. Corporate insiders own 7.80% of the company’s stock.

About Stryker Corporation

Stryker Corporation (Stryker) is a medical technology company. The Company operates through three segments: Orthopaedics, MedSurg, and Neurotechnology and Spine. The Company’s Orthopaedics segment products consist of implants used in hip and knee joint replacements and trauma and surgeries. The Company’s MedSurg segment products consist of surgical equipment and surgical navigation systems (Instruments); endoscopic and communications systems (Endoscopy); patient handling and emergency medical equipment (Medical), and reprocessed and remanufactured medical devices (Sustainability), as well as other medical device products used in a range of medical specialties.

5 Day Chart for NYSE:SYK

Want to see what other hedge funds are holding SYK? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Stryker Corporation (NYSE:SYK).

Receive News & Ratings for Stryker Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Stryker Corporation and related companies with Analyst Ratings Network's FREE daily email newsletter.